This right here is why you've got to play the long game with Clarity. Proprietary technology that can be applied to unmet clinical needs in a large range of cancer types, to produce, potentially, best-in-class radiopharmaceuticals. I love Telix for what they have pioneered in the field, but Clarity are miles ahead in terms of intellectual property. And working in the field of oncology with leading experts in Theranostics...Copper is the future.
Ann: Clarity expands pipeline with Cu-64/67 SAR-trastuzumab, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.11 |
Change
-0.200(4.64%) |
Mkt cap ! $1.329B | |||
| Open | High | Low | Value | Volume |
| $4.20 | $4.27 | $4.09 | $7.447M | 1.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $4.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.12 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |